These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 2867911

  • 1. A central site of dopamine agonist action to modify gastric secretion in the rat.
    Costall B, Naylor RJ, Tan CC.
    Eur J Pharmacol; 1985 Oct 29; 117(1):61-9. PubMed ID: 2867911
    [Abstract] [Full Text] [Related]

  • 2. The sites and mechanisms of action of 2-di-n-propylamino-5, 6-dihydroxytetralin in the hypothalamus of the rat to modify gastric secretion.
    Costall B, Naylor RJ, Tan CC.
    Neuropharmacology; 1986 Jul 29; 25(7):681-7. PubMed ID: 2875416
    [Abstract] [Full Text] [Related]

  • 3. Mechanism of action of apomorphine on rat gastric secretion.
    Costall B, Naylor RJ, Tan CC.
    Eur J Pharmacol; 1985 Oct 22; 116(3):279-85. PubMed ID: 2866967
    [Abstract] [Full Text] [Related]

  • 4. The mesolimbic nucleus accumbens is critically involved with the mediation of the motor inhibitory and facilitatory effects of dopamine agonists on mouse spontaneous climbing behaviour.
    Costall B, Eniojukan JF, Naylor RJ.
    Eur J Pharmacol; 1983 Dec 23; 96(3-4):201-10. PubMed ID: 6426976
    [Abstract] [Full Text] [Related]

  • 5. Characterisation of the mechanisms by which purported dopamine agonists reduce spontaneous locomotor activity of mice.
    Costall B, Lim SK, Naylor RJ.
    Eur J Pharmacol; 1981 Jul 17; 73(2-3):175-88. PubMed ID: 6118281
    [Abstract] [Full Text] [Related]

  • 6. A central site of action for benzamide facilitation of gastric emptying.
    Costall B, Gunning SJ, Naylor RJ, Simpson KH.
    Eur J Pharmacol; 1983 Jul 22; 91(2-3):197-205. PubMed ID: 6617741
    [Abstract] [Full Text] [Related]

  • 7. Catecholamine receptors involved in the inhibitory effects of dopamine on vagally stimulated gastric acid secretion and mucosal blood flow in rats.
    Nishikawa H, Yokotani K, Fujiwara M.
    J Pharmacol Exp Ther; 1987 Mar 22; 240(3):966-71. PubMed ID: 3031280
    [Abstract] [Full Text] [Related]

  • 8. Inhibition and facilitation of motor responding of the mouse by actions of dopamine agonists in the forebrain.
    Bradbury AJ, Costall B, Naylor RJ.
    Neuropharmacology; 1984 Sep 22; 23(9):1025-31. PubMed ID: 6514141
    [Abstract] [Full Text] [Related]

  • 9. Interaction of the component enantiomers of the putative dopamine autoreceptor agonist, TL-99 (6,7-dihydroxy-2-dimethylamino tetralin) with dopaminergic systems in mammalian brain and teleost retina.
    Williams M, Martin GE, McClure DE, Baldwin JJ, Watling KJ.
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Dec 22; 324(4):275-80. PubMed ID: 6141532
    [Abstract] [Full Text] [Related]

  • 10. Pharmacological characterization of 8-OH-DPAT-induced inhibition of rat hippocampal 5-HT release in vivo as measured by microdialysis.
    Sharp T, Bramwell SR, Hjorth S, Grahame-Smith DG.
    Br J Pharmacol; 1989 Nov 22; 98(3):989-97. PubMed ID: 2574066
    [Abstract] [Full Text] [Related]

  • 11. 5-HT1A and alpha-2 adrenergic receptors mediate the hyperglycemic and hypoinsulinemic effects of 8-hydroxy-2-(di-n-propylamino)tetralin in the conscious rat.
    Chaouloff F, Jeanrenaud B.
    J Pharmacol Exp Ther; 1987 Dec 22; 243(3):1159-66. PubMed ID: 2826757
    [Abstract] [Full Text] [Related]

  • 12. The alpha 2-adrenoceptor antagonist atipamezole potentiates anti-Parkinsonian effects and can reduce the adverse cardiovascular effects of dopaminergic drugs in rats.
    Haapalinna A, Leino T, Heinonen E.
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Nov 22; 368(5):342-51. PubMed ID: 14566451
    [Abstract] [Full Text] [Related]

  • 13. Influence of dopamine receptor agonists on gastric acid secretion induced by intraventricular administration of thyrotropin-releasing hormone in the perfused stomach of anaesthetized rats.
    Maeda-Hagiwara M, Watanabe K.
    Br J Pharmacol; 1983 May 22; 79(1):297-303. PubMed ID: 6135480
    [Abstract] [Full Text] [Related]

  • 14. Reduction in motor responding of the mouse by actions of dopamine agonists in the midbrain.
    Bradbury AJ, Costall B, Naylor RJ.
    Neuropharmacology; 1983 Oct 22; 22(10):1171-6. PubMed ID: 6646352
    [Abstract] [Full Text] [Related]

  • 15. Modification of dyskinesias following the intrastriatal injection of prostaglandins in the rodent.
    Costall B, Holmes SW, Kelly ME, Naylor RJ.
    Br J Pharmacol; 1985 Aug 22; 85(4):943-9. PubMed ID: 3862460
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A dopamine D3 receptor agonist, 7-hydroxy-N,N-di-n-propyl-2-aminotetralin, reduces gastric acid and pepsin secretion and experimental gastric mucosal injury in rats.
    Glavin GB.
    Life Sci; 1995 Aug 22; 56(4):287-93. PubMed ID: 7823787
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Further investigation of the in vivo pharmacological properties of the putative 5-HT1A antagonist, BMY 7378.
    Sharp T, Backus LI, Hjorth S, Bramwell SR, Grahame-Smith DG.
    Eur J Pharmacol; 1990 Feb 13; 176(3):331-40. PubMed ID: 1970304
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.